Policy Perspective
Joint Association Letter on Industrial Hemp
COGR, the Association of American Universities, and the Association of Public and Land-grant Universities sent this letter to congressional leaders to advocate for the inclusion of Senate provisions in the final 2018 Farm Bill that would remove federal regulatory barriers to industrial hemp research. Specifically, they request explicit federal guidance allowing university researchers to obtain, gr
COGR Submits Letter to DEA Regarding Production Quotas for Schedule I & II Controlled Substances
COGR submitted formal comments to the U.S. Drug Enforcement Administration (DEA) regarding the proposed 2019 aggregate production quotas for Schedule I and II controlled substances, with particular attention to marijuana and its derivatives. COGR expressly supports the proposed increase in production quotas for marijuana and tetrahydrocannabinols, seeing this as a constructive move to advance scie
Joint Association Letter to EPA on Proposed Rule to Limit Scientific Research
COGR, along with the AAMC, AAU and APLU submit their joint letter to the Environmental Protection Agency (EPA) opposing a proposed rule that seeks to limit the scientific research it will consider unless all underlying data are made publicly available.
NIH Basic Science Studies and Clinical Trials: Next Step
The document outlines the National Institutes of Health’s (NIH) next steps regarding the application and enforcement of clinical trial policies for basic science studies. For all trials not classified as basic science, NIH will continue with existing policy enforcement. However, for basic science studies, NIH will delay the enforcement of the policy on registration and reporting, originally posted
